Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Adverse consequences of lysergic acid diethylamide.

Abraham HD, Aldridge AM.

Addiction. 1993 Oct;88(10):1327-34. Review.

PMID:
8251869
2.

[Hallucinogen-induced psychological disorders].

Hermle L, Kovar KA, Hewer W, Ruchsow M.

Fortschr Neurol Psychiatr. 2008 Jun;76(6):334-42. doi: 10.1055/s-2008-1038191. Review. German.

PMID:
18512184
3.

Do hallucinogens cause residual neuropsychological toxicity?

Halpern JH, Pope HG Jr.

Drug Alcohol Depend. 1999 Feb 1;53(3):247-56. Review.

PMID:
10080051
4.

The pharmacology of lysergic acid diethylamide: a review.

Passie T, Halpern JH, Stichtenoth DO, Emrich HM, Hintzen A.

CNS Neurosci Ther. 2008 Winter;14(4):295-314. doi: 10.1111/j.1755-5949.2008.00059.x. Review.

PMID:
19040555
5.

Unfavourable reactions to LSD: a review and analysis of the available case reports.

Smart RG, Bateman K.

Can Med Assoc J. 1967 Nov 11;97(20):1214-21. Review. No abstract available.

6.

Adverse reactions to psychedelic drugs. A review of the literature.

Strassman RJ.

J Nerv Ment Dis. 1984 Oct;172(10):577-95. Review.

PMID:
6384428
7.

Serotonin research: contributions to understanding psychoses.

Geyer MA, Vollenweider FX.

Trends Pharmacol Sci. 2008 Sep;29(9):445-53. doi: 10.1016/j.tips.2008.06.006. Review.

PMID:
19086254
8.

Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.

Westkaemper RB, Glennon RA.

NIDA Res Monogr. 1994;146:263-83. Review. No abstract available.

PMID:
8742803
9.

Quantified LSD effects on ego strength.

Marrazzi AS, Meisch RA, Pew WL, Bieter TG.

Recent Adv Biol Psychiatry. 1966;9:197-207. Review. No abstract available.

PMID:
4386665
10.

Long-term psychological effects of LSD.

McWilliams SA, Tuttle RJ.

Psychol Bull. 1973 Jun;79(6):341-51. Review. No abstract available.

PMID:
4575027
11.

Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects.

Strassman RJ.

J Nerv Ment Dis. 1995 Mar;183(3):127-38. Review.

PMID:
7891058
12.

Hallucinogen persisting perception disorder: what do we know after 50 years?

Halpern JH, Pope HG Jr.

Drug Alcohol Depend. 2003 Mar 1;69(2):109-19. Review.

PMID:
12609692
13.
14.
15.

Rave drugs: pharmacological considerations.

Klein M, Kramer F.

AANA J. 2004 Feb;72(1):61-7. Review.

PMID:
15098519
17.

LSD. Its rise, fall, and renewed popularity among high school students.

Schwartz RH.

Pediatr Clin North Am. 1995 Apr;42(2):403-13. Review.

PMID:
7724266
18.

[Experimental and clinical pharmacological aspects of the hallucinogen LSD-25].

Nisticò G.

Clin Ter. 1968 Oct 31;47(2):119-60. Review. Italian. No abstract available.

PMID:
4883264
19.

Serotonergic mechanisms of hallucinogenic drug effects.

Heym J, Jacobs BL.

Monogr Neural Sci. 1987;13:55-81. Review. No abstract available.

PMID:
2891030
20.

The problems of LSD-25 and emotional disorder.

Ungerleider JT, Fisher DD.

Calif Med. 1967 Jan;106(1):49-55. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk